These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 3907144)
1. [Method for the simultaneous detection of immunofluorescing antibodies to the causative agents of different hemorrhagic fevers]. Lukashevich IS; van der Groen G Vopr Virusol; 1985; 30(5):624-6. PubMed ID: 3907144 [No Abstract] [Full Text] [Related]
2. Preparation of polyvalent viral immunofluorescent intracellular antigens and use in human serosurveys. Johnson KM; Elliott LH; Heymann DL J Clin Microbiol; 1981 Nov; 14(5):527-9. PubMed ID: 7031084 [TBL] [Abstract][Full Text] [Related]
3. Use of betapropionolactone inactivated Ebola, Marburg and Lassa intracellular antigens in immunofluorescent antibody assay. Van der Groen G; Elliot LH Ann Soc Belg Med Trop; 1982 Mar; 62(1):49-54. PubMed ID: 7049096 [No Abstract] [Full Text] [Related]
4. [Research with the Marburg, Lassa and Ebola viruses]. Pshenichnov VA; Makhlaĭ AA; Mikhaĭlov VV Vopr Virusol; 1993; 38(2):54-8. PubMed ID: 8059520 [No Abstract] [Full Text] [Related]
5. Haemorrhagic fever in Gabon. I. Incidence of Lassa, Ebola and Marburg viruses in Haut-Ogooué. Ivanoff B; Duquesnoy P; Languillat G; Saluzzo JF; Georges A; Gonzalez JP; McCormick J Trans R Soc Trop Med Hyg; 1982; 76(6):719-20. PubMed ID: 7164137 [TBL] [Abstract][Full Text] [Related]
6. [Indirect immunoenzyme method for the laboratory diagnosis of Lassa and Ebola hemorrhagic fevers]. Ivanov AP; Tkachenko EA; van der Groen G; Butenko AM; Konstantinov OK Vopr Virusol; 1986; 31(2):186-90. PubMed ID: 3524001 [TBL] [Abstract][Full Text] [Related]
7. Viral haemorrhagic fever antibodies in Zimbabwe schoolchildren. Blackburn NK; Searle L; Taylor P Trans R Soc Trop Med Hyg; 1982; 76(6):803-5. PubMed ID: 6761909 [No Abstract] [Full Text] [Related]
9. Viral haemorrhagic fevers caused by Lassa, Ebola and Marburg viruses. Curtis N Adv Exp Med Biol; 2006; 582():35-44. PubMed ID: 16802617 [No Abstract] [Full Text] [Related]
10. [Marburg, Ebole and Lassa virus infections]. Denis F; Robin Y Dakar Med; 1979; 24(1):51-5. PubMed ID: 574072 [No Abstract] [Full Text] [Related]
11. Antibodies against haemorrhagic fever viruses in Kenya populations. Johnson BK; Ocheng D; Gichogo A; Okiro M; Libondo D; Tukei PM; Ho M; Mugambi M; Timms GL; French M Trans R Soc Trop Med Hyg; 1983; 77(5):731-3. PubMed ID: 6419422 [TBL] [Abstract][Full Text] [Related]
16. Laboratory diagnostic systems for Ebola and Marburg hemorrhagic fevers developed with recombinant proteins. Saijo M; Niikura M; Ikegami T; Kurane I; Kurata T; Morikawa S Clin Vaccine Immunol; 2006 Apr; 13(4):444-51. PubMed ID: 16603611 [No Abstract] [Full Text] [Related]
17. Antibodies to haemorrhagic fever viruses in Madagascar populations. Mathiot CC; Fontenille D; Georges AJ; Coulanges P Trans R Soc Trop Med Hyg; 1989; 83(3):407-9. PubMed ID: 2515626 [TBL] [Abstract][Full Text] [Related]
18. Management of patients with suspected viral hemorrhagic fever. Centers for Disease Control (CDC) MMWR Suppl; 1988 Feb; 37(3):1-16. PubMed ID: 3126390 [No Abstract] [Full Text] [Related]
19. [Viral hemorrhagic fevers in man]. Simpson DI Bull World Health Organ; 1979; 57(1):19-32. PubMed ID: 34489 [No Abstract] [Full Text] [Related]